Venmax Drugs & Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Venmax Drugs & Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Venmax Drugs & Pharmaceuticals Ltd.

29 Mar 2021

25.10

-4.92%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - TO CONSIDER AND APPROVE SEGREGATION OF SHAREHOLDING OF …

BSE India

With reference to the letter received from Stock exchange, vide Ref. No: DCS/ALF/PS/Seeking details - Promoters/609-315/2020-21 dated 08.03.2021, the Board of directors of the Company approved the revised shareholding pattern, clearly segregating between promoter and promoter group.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

19 Mar 2021

25.10

-4.92%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for TO CONSIDER AND APPROVE …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2021 ,inter alia, to consider and approve SEGREGATION OF SHAREHOLDING OF PROMOTER AND PROMOTER GROUP

pdf

Venmax Drugs & Pharmaceuticals Ltd.

13 Feb 2021

25.10

-4.92%

Result

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Unaudited Financial Results For The Quarter Ended 31.12.2020

BSE India

Unaudited Financial Results for the Quarter ended 31.12.2020

pdf

Venmax Drugs & Pharmaceuticals Ltd.

06 Feb 2021

25.10

-4.92%

Board Meeting

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve Unaudited Financial results for the quarter ended 31/12/2020

pdf

Venmax Drugs & Pharmaceuticals Ltd.

23 Jan 2021

25.10

-4.92%

Company Update

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Cancellation of Board Meeting

BSE India

The Board Meeting to be held on 23/01/2021 Stands Cancelled.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

21 Jan 2021, 10:47AM

25.10

-4.92%

Company Update

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Shareholding for the Period Ended December 31, 2020

BSE India

Venmax Drugs and Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

Venmax Drugs & Pharmaceuticals Ltd.

21 Jan 2021, 10:39AM

25.10

-4.92%

Company Update

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Statement Of Investor Complaints For The Quarter Ended December 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Raj Kumar RaiDesignation :- Managing Director / Whole Time Director

Venmax Drugs & Pharmaceuticals Ltd.

15 Jan 2021

25.10

-4.92%

Board Meeting

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Consideration And Approval Of …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2021 ,inter alia, to consider and approve un-audited financial results for the quarter ended 31.12.2020

pdf

Venmax Drugs & Pharmaceuticals Ltd.

09 Jan 2021

25.10

-4.92%

Company Update

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Cancellation of Board Meeting

BSE India

The Board Meeting to be held on 11/01/2021 Stands Cancelled.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

05 Jan 2021

25.10

-4.92%

Board Meeting

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2021 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter ended 31.12.2020

pdf

Is Venmax Drugs & Pharmaceuticals Ltd. worth buying?

8 Votes:

Buy 87.5%

Sell 12.5%